Jounce Therapeutics OverviewJounce Therapeutics Net Income
Profitability analysis for JNCE.
Quarterly Net Income
$50.96M
↑ 169752.01% YoY
As of Dec 2022
Annual Net Income (TTM)
-$50.92M
↑ 15.99% YoY
Trailing 12 months ending Dec 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...